Top Pharmaceuticals companies in Denmark by Operating Income

This ranking features the top 19 Pharmaceuticals companies in Denmark ranked by Operating Income, totalling a Operating Income of USD 17.93 B, for January 15, 2025.
#
Name
Operating Income
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 15.18 B
Dec. 31, 2023 USD 81.56 -2.90%

Denmark

2
USD 1.09 B
Sept. 30, 2024 USD 109.06 -0.12%

Denmark

3
USD 787.61 M
Dec. 31, 2023 USD 216.88 1.28%

Denmark

4
USD 588.53 M
Dec. 31, 2023 USD 54.16 -1.39%

Denmark

5
USD 472.92 M
Dec. 31, 2023 USD 5.46 0.56%

Denmark

6
USD 221.66 M
Dec. 31, 2023 USD 26.62 -0.36%

Denmark

7
USD 98.58 M
Dec. 31, 2023 USD 20.15 -0.78%

Denmark

8
USD 96.25 M
Sept. 30, 2024 USD 18.73 1.26%

Denmark

9
USD 25.74 M
June 30, 2024 USD 70.50 0.61%

Denmark

10
USD -4.00 K
Dec. 31, 2023 USD 0.64 1.38%

Denmark

11
USD -1.42 M
Dec. 31, 2023 USD 0.85 -3.38%

Denmark

12
USD -1.86 M
Dec. 31, 2023 USD 1.93 -6.19%

Denmark

13
USD -6.46 M
Dec. 31, 2023 USD 3.98 0.01%

Denmark

14
USD -7.31 M
Dec. 31, 2023 USD 91.43 -1.85%

Denmark

15
USD -8.00 M
Dec. 31, 2023 USD 0.57 1.47%

Denmark

16
USD -9.05 M
Dec. 31, 2023 USD 0.20 -2.77%

Denmark

17
USD -10.46 M
Dec. 31, 2023 USD 2.17 5.88%

Denmark

18
USD -84.70 M
Dec. 31, 2023 USD 95.84 0.08%

Denmark

19
USD -502.80 M
Dec. 31, 2023 USD 131.57 -1.84%

Denmark

Frequently Asked Questions
  • Which Pharmaceuticals company in Denmark has the highest Operating Income ?

    The Pharmaceuticals company in Denmark with the highest Operating Income is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 15.18 B.

  • Which Pharmaceuticals company in Denmark has the lowest Operating Income ?

    The Pharmaceuticals company in Denmark with the lowest Operating Income is Ascendis Pharma A/S (NasdaqGS: ASND) at USD -502.80 M.